MATTHEW HAROLD KATZ to Bilirubin
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Bilirubin.
Connection Strength
0.155
-
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). 2014 May; 16(5):430-8.
Score: 0.106
-
Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol. 2022 Nov; 126(6):1021-1027.
Score: 0.049